Achieving inclusivity for minorities in clinical trials; Why local knowledge is key for pharmacovigilance; EU vs US trends in ...
It’s exactly what Medscape Education did by launching our award-winning Hear From Her: Women in Healthcare Leadership podcast ...
True ‘patient-centricity’ goes beyond treating disease—it means ensuring that patient voices shape research, decision-making, ...
Sanofi and Regeneron’s Dupixent (dupilumab) has been accepted for priority review by the US Food and Drug Administration (FDA ...
The phase 3 NIAGARA trial randomised 1,063 MIBC patients to receive Imfinzi plus neoadjuvant chemotherapy prior to bladder ...
Merck & Co’s – known as MSD outside of the US and Canada – Welireg (belzutifan) has been conditionally approved by the ...